The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis.
María Hernández-PérezDaniel RiadoEva PenaCarmen MéndezFernando PinedoPaloma RamosPilar CastilloMiriam RomeroConrado M Fernández RodríguezAntonio OlveiraPublished in: Alimentary pharmacology & therapeutics (2024)
Our findings suggest that metabolic dysfunction-associated steatotic liver disease worsens the prognosis of PBC.